Fig. 6

CLP treatment enhances the PPARα/CPT-1/MCAD signaling in the liver of HFD-fed mice. The relative levels of PPARα, CPT-1 and MCAD expression in the liver of individual mice were analyzed by qRT-PCR and Western blotting. A-C qRT-PCR analyses of the relative expressions of PPARα, CPT-1, and MCAD in the liver of the indicated groups of mice. D-F Western blotting analyses of the relative levels of PPARα, CPT-1, and MCAD in the liver of the indicated groups mice. NC: The control; HFD: The HFD-fed mice receiving vehicle treatment; CLP-50: The HFD-fed mice receiving 50 mg/kg/d CLP; CLP-150: The HFD-fed mice receiving 150 mg/kg/d CLP. Data were analyzed by student's t test and expressed as the mean ± SEM.^*P < 0.05 vs. the NC group; ^#P < 0.05 vs. the HFD group